Yes. We support biopharma organizations with inspection readiness through expert assessments, mock inspections, remediation planning, and hands-on preparation of teams, systems, and documentation. The goal is not only to answer questions during an inspection, but to ensure the site can stand up credibly under regulatory scrutiny.

Yes. We help biopharma manufacturers strengthen sterility assurance and contamination control through practical, risk-based support aligned with Annex 1 expectations. This includes Contamination Control Strategy development, risk assessments, environmental monitoring, gowning qualification, aseptic behaviors, and material transfer controls.

Yes. We help sponsors and biopharma companies strengthen oversight of CDMOs, suppliers, and external manufacturing partners through structured governance, risk-based prioritization, Quality oversight routines, and clearer accountability. This is especially important where critical GMP activities are outsourced but regulatory responsibility remains with the client.

We do both. GMP Bridge supports clients from assessment and strategy through to hands-on implementation. Our senior consultants work directly with client teams to improve processes, simplify and strengthen Quality Systems, close compliance gaps, and embed sustainable GMP improvements in daily operations.